Jasper Therapeutics CFO Herb Cross resigns effective Oct. 9

• Jasper Therapeutics CFO Herb Cross resigned effective Oct. 9 to pursue other professional opportunities.
• CEO Jeet Mahal was named interim principal financial officer effective with Cross’ departure.
• Vice President, Finance Rick Ruiz was appointed interim principal accounting officer; he joined in 2024 with 25+ years in accounting, FP&A, financing, SEC reporting.
• Chief Operating Officer Matthew Ros was named interim corporate secretary effective Oct. 9.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-104101), on September 28, 2026, and is solely responsible for the information contained therein.